{"meshTagsMajor":["Polymorphism, Genetic","Genes, p53"],"meshTags":["Nuclear Proteins","Polymorphism, Single Nucleotide","Female","Male","Tumor Suppressor Proteins","Apoptosis","DNA Repair","DNA-Binding Proteins","Serine","Polymorphism, Genetic","Cyclin-Dependent Kinase Inhibitor p21","Tumor Protein p73","Proline","Humans","Genes, p53","Arginine","Tumor Suppressor Protein p53","Skin Neoplasms"],"meshMinor":["Nuclear Proteins","Polymorphism, Single Nucleotide","Female","Male","Tumor Suppressor Proteins","Apoptosis","DNA Repair","DNA-Binding Proteins","Serine","Cyclin-Dependent Kinase Inhibitor p21","Tumor Protein p73","Proline","Humans","Arginine","Tumor Suppressor Protein p53","Skin Neoplasms"],"genes":["TP53 Arg72Pro","p73 G4C14\u003eA4TA4","p21 Ser31Arg"],"publicationTypes":["Letter","Research Support, N.I.H., Extramural"],"title":"Polymorphisms of TP53 Arg72Pro, but not p73 G4C14\u003eA4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.","pubmedId":"18049450"}